A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M1 receptor agonist HTL0018318 in patients with mild‐to‐moderate Alzhe... von Nathan, Pradeep J., Millais, S. Babli, Godwood, Alex, Dewit, Odile, Cross, David M., Liptrot, Janet, Ruparelia, Bharat, Jones, Stephen Paul, Bakker, Geor, Maruff, Paul T., Light, Gregory A., Brown, Alastair J.H., Weir, Malcolm Peter, Congreve, Miles, Tasker, Tim

Volltext

A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M 1 receptor agonist HTL0018318 in patients with mild-to-moderate Alzh... von Nathan, Pradeep J, Millais, S Babli, Godwood, Alex, Dewit, Odile, Cross, David M, Liptrot, Janet, Ruparelia, Bharat, Jones, Stephen Paul, Bakker, Geor, Maruff, Paul T, Light, Gregory A, Brown, Alastair J H, Weir, Malcolm Peter, Congreve, Miles, Tasker, Tim

Volltext

A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M1 receptor agonist HTL0018318 in patients with mild-to-moderate Alzhe... von Nathan, Pradeep J, Millais, S Babli, Godwood, Alex, Dewit, Odile, Cross, David M, Liptrot, Janet, Ruparelia, Bharat, Jones, Stephen Paul, Bakker, Geor, Maruff, Paul T, Light, Gregory A, Brown, Alastair JH, Weir, Malcolm Peter, Congreve, Miles, Tasker, Tim

Volltext bestellen

P3‐025: USE OF A MODIFIED HIDDEN PATHWAY MAZE TEST IN PATIENTS WITH ALZHEIMER'S DISEASE DEMENTIA von Edgar, Chris J., Tasker, Tim, Schembri, Adrian, Millais, Babli, Ruparelia, Bharat, Dewit, Odile, Jones, Stephen, Maruff, Paul, Nathan, Pradeep J.

Volltext

USE OF A MODIFIED HIDDEN PATHWAY MAZE TEST IN PATIENTS WITH ALZHEIMER’S DISEASE DEMENTIA von Edgar, Chris J., Tasker, Tim, Schembri, Adrian, Millais, Babli, Ruparelia, Bharat, Dewit, Odile, Jones, Stephen, Maruff, Paul, Nathan, Pradeep J.

Volltext